ArticleTherapeutic advances in medical oncology2022

Cost-effectiveness analysis of Oncotype DX from a Brazilian private medicine perspective: a GBECAM multicenter retrospective study.

Leandro Jonata Carvalho Oliveira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.